Daxor Management
Management criteria checks 3/4
Daxor's CEO is Michael Feldschuh, appointed in Sep 2016, has a tenure of 8.67 years. directly owns 4.31% of the company’s shares, worth €1.46M. The average tenure of the management team and the board of directors is 6.7 years and 6.6 years respectively.
Key information
Michael Feldschuh
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.7yrs |
| CEO ownership | 4.3% |
| Management average tenure | 6.7yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | US$536k |
| Sep 30 2024 | n/a | n/a | US$1m |
| Jun 30 2024 | n/a | n/a | US$2m |
| Mar 31 2024 | n/a | n/a | US$984k |
| Dec 31 2023 | n/a | n/a | US$281k |
| Sep 30 2023 | n/a | n/a | US$2m |
| Jun 30 2023 | n/a | n/a | US$4m |
| Mar 31 2023 | n/a | n/a | US$5m |
| Dec 31 2022 | US$100k | US$100k | US$5m |
| Sep 30 2022 | n/a | n/a | US$5m |
| Jun 30 2022 | n/a | n/a | US$4m |
| Mar 31 2022 | n/a | n/a | US$5m |
| Dec 31 2021 | US$100k | US$100k | US$5m |
| Sep 30 2021 | n/a | n/a | US$3m |
| Jun 30 2021 | n/a | n/a | US$294k |
| Mar 31 2021 | n/a | n/a | -US$706k |
| Dec 31 2020 | US$100k | US$100k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$100k | US$100k | -US$496k |
| Sep 30 2019 | n/a | n/a | -US$149k |
| Jun 30 2019 | n/a | n/a | US$197k |
| Mar 31 2019 | n/a | n/a | -US$344k |
| Dec 31 2018 | US$100k | US$100k | -US$886k |
Compensation vs Market: Insufficient data to establish whether Michael's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Feldschuh (55 yo)
8.7yrs
Tenure
US$100,000
Compensation
Mr. Michael Richard Feldschuh has been the Chief Executive Officer and President of Daxor Corp. since September 21, 2016. Mr. Feldschuh served as Acting Chief Executive Officer and President of Daxor Corp....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer & Director | no data | US$127.92k | 0.73% € 246.6k | |
| Chairman | 8.7yrs | US$100.00k | 4.31% € 1.5m | |
| CFO, Chief Compliance Officer & Corporate Secretary | 6.7yrs | no data | 0.35% € 117.1k | |
| Vice President of Development & Operations | 2.3yrs | no data | no data | |
| Senior VP of Marketing & Commercial Development | 6.9yrs | no data | no data | |
| Chief Medical Officer | 1yr | no data | no data |
6.7yrs
Average Tenure
59yo
Average Age
Experienced Management: DX5's management team is seasoned and experienced (6.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer & Director | 8.3yrs | US$127.92k | 0.73% € 246.6k | |
| Chairman | 12.3yrs | US$100.00k | 4.31% € 1.5m | |
| Chairman of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 3.3yrs | US$1.75k | 0.064% € 21.7k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 9.3yrs | US$2.13k | 0.020% € 6.9k | |
| Independent Director | 4.9yrs | US$1.13k | 0% € 0 | |
| Independent Director | 4.9yrs | US$2.13k | 0.0061% € 2.1k |
6.6yrs
Average Tenure
66yo
Average Age
Experienced Board: DX5's board of directors are considered experienced (6.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 15:11 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daxor Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anthony Vendetti | Maxim Group |
| Scott Henry | Roth Capital Partners |